SPRYCEL 50 mg film-coated tablets

DRUG2 trials

Sponsors

Region Uppsala, Centre Hospitalier Universitaire De Poitiers

Conditions

Chronic Myeloid LeukemiaChronic myeloid leukemia

Phase 2

Persistence of major molecular remission in chronic myeloid leukemia after a second stop of TKI treatment in patients who failed an initial stop attempt: a multicenter prospective trial. DASTOP2 TRIAL

RecruitingCTIS2024-515409-25-00

Region UppsalaChronic myeloid leukemia

Start: 2018-01-11Target: 32Updated: 2025-03-03

Phase 3

AITIK-Discontinuation of TyrosIne Kinase Inhibitors (ITK) in Chronic Myeloid Leukemia (LMC) and Impact on the Immune System: a Randomized Comparative Study of Two Therapeutic Strategies

Active, not recruitingCTIS2024-515479-36-00

Centre Hospitalier Universitaire De PoitiersChronic Myeloid Leukemia

Start: 2023-07-05Target: 170Updated: 2025-06-05